DOI:

Detection of a necrotic core-rich, highly deformable plaque in an angiographically non-diseased proximal LAD

Gastón A. Rodriguez-Granillo, MD; Raquel del Valle, MD; Jurgen Ligthart, BSc; Patrick W. Serruys*, MD, PhD

Thin-cap fibro atheroma (TCFA) lesions, the most prevalent precursor of plaque rupture, are composed of a lipid-rich necrotic core, a thin-fibrous cap with macrophage and lymphocyte infiltration, decreased smooth muscle cell content and expansive remodeling. Virtual Histology™ uses spectral analysis of intravascular ultrasound (IVUS) radiofrequency data to construct tissue maps that classify plaque into four major components; calcified, fibrous, fibrolipidic and necrotic core regions that are labeled white, green, greenish-yellow and red respectively. Palpography™ evaluates in vivo the mechanical properties of plaque tissue. The local strain is calculated from the radiofrequency traces using cross-correlation analysis and displayed, colour coded, from blue (for 0% strain) through yellow (for 2% strain) via red (Figure 1).

At a defined pressure, soft tissue (lipid-rich) components will deform more than hard (fibrous-calcified) components. Both techniques have been previously validated1,2.

Figure 1a shows an angiographically non-diseased proximal left anterior descending (LAD) artery. IVUS longitudinal reconstruction (Figure 1b) shows diffuse LAD disease. An eccentric mixed plaque that did not compromise the lumen was detected in the proximal LAD (Figure 1c). This segment was further analyzed with Palpography (20 MHz Eagle Eye, Volcano Therapeutics) and Virtual Histology™ (30 MHz Ultracross, Boston Scientific Corp) (Figures 1d and 1e). Despite its innocuous appearance on gray-scale IVUS, highly deformable shoulders with an underlying necrotic core-rich substrate were detected with the aid of strain and compositional imaging.

Although compatible with the presence of a vulnerable plaque, the prognostic value of these findings is currently unknown and needs to be established in large prospective randomized trials. Thus, the patient was discharged on intensive systemic therapy including lipid-lowering agents.

Figure 1. LAD= left anterior descending coronary artery. LCx= Left circumflex coronary artery. LMCA= Left main coronary artery. * Pericardium.

Volume 1 Number 3
Nov 20, 2005
Volume 1 Number 3
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-24-00052 Nov 18, 2024
Low-flow, low-gradient aortic stenosis: an understanding is still a long way off
Webb J and Offen S
free

Debate

10.4244/EIJ-E-24-00054 Nov 18, 2024
TAVI patients with bystander coronary artery disease should receive PCI: pros and cons
Rodés-Cabau J et al
free

EAPCI Column

Nov 18, 2024
EAPCI at PCR London Valves 2024
free

Original Research

10.4244/EIJ-D-24-00442 Nov 18, 2024
Long-term survival after TAVI in low-flow, low-gradient aortic valve stenosis
Cardaioli F et al

Original Research

10.4244/EIJ-D-24-00367 Nov 18, 2024
Feasibility of redo-TAVI in the self-expanding ACURATE neo2 valve: a computed tomography study
Bieliauskas G et al
Trending articles
152.9

Clinical research

10.4244/EIJ-D-20-01125 Oct 20, 2021
An upfront combined strategy for endovascular haemostasis in transfemoral transcatheter aortic valve implantation
Costa G et al
free
47.8

NEW INNOVATION

10.4244/EIJ-D-15-00467 Feb 20, 2018
Design and principle of operation of the HeartMate PHP (percutaneous heart pump)
Van Mieghem NM et al
free
39.1

Clinical research

10.4244/EIJ-D-22-00558 Feb 6, 2023
Permanent pacemaker implantation and left bundle branch block with self-expanding valves – a SCOPE 2 subanalysis
Pellegrini C et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved